Rakuten Medical, Inc. is a global biotechnology company developing and commercializing precision, cell-targeting investigational therapies on its AlluminoxTM platform, which, in pre-clinical studies have been shown to induce rapid and selective cell killing and tumor necrosis. Outside of Japan, Alluminox therapies have not yet been approved as safe or effective by any regulatory authority. The company’s first drug developed on the Alluminox platform, ASP-1929, has received approval from the Japanese Ministry of Health, Labour, and Welfare, and is currently the subject of a global phase 3 clinical trial for recurrent head and neck cancer. Rakuten Medical is committed to its mission to conquer cancer by delivering our innovative treatments as quickly and safely as possible to as many patients all over the world as possible. The company has locations in 6 countries, including the United States, where it is headquartered, Japan, Taiwan, the Netherlands, Switzerland and India. For more information, visit www.rakuten-med.com.
Location: United States, California, San Diego
Employees: 201-500
Total raised: $285M
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | ABC Partne... | abc-partne... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 07.03.2024 | Series E | $119M | - |
| 02.08.2021 | Series D | $166M | - |
Mentions in press and media 17
| Date | Title | Description | Source |
| 19.03.2024 | The Japanese Head and Neck Cancer Society and Rakuten Medica... | The Japanese Head and Neck Cancer Society and Rakuten Medical will hold a disease awareness event “R... | re-how.net... |
| 11.03.2024 | Rakuten Medical Secures $119M in Series E Funding | Rakuten Medical, a biotechnology company focused on precision therapies for cancer treatment, has su... | parsers.vc... |
| 07.03.2024 | Rakuten Medical Gets $119M In Series E | Rakuten medical, a company developing precision therapies for treating cancer, has raised $119M in a... | socaltech.... |
| 07.03.2024 | Rakuten Medical Closes $119M Series E Financing | Rakuten Medical, a San Diego, CA-based biotechnology company developing and commercializing precisio... | finsmes.co... |
| 06.03.2024 | Rakuten Medical Completes $119M Series E round to continue d... | - | connect.or... |
| 07.01.2022 | Rakuten Medical begins development of light irradiation tech... | Leave a Reply Cancel reply | re-how.net... |
| 10.08.2021 | Rakuten Medical Announces Two New Members to Board of Direct... | prnewswire... | |
| 03.08.2021 | Someone’s going to hurt from the streaming wars. Blackstone’... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 02.08.2021 | Rakuten Medical Closes $166M in Series D Funding | Rakuten Medical, a San Mateo CA-based biotechnology company focused on developing and commercializin... | finsmes.co... |
| 29.07.2021 | Rakuten Medical rakes in $166M series D following drug-devic... | Ten months after securing its first drug approval for head and neck cancer in Japan, Rakuten Medical... | fiercebiot... |
Show more